BIOCYTOGEN PHARMA. H YC1 Defensive Interval Ratio
BIOCYTOGEN PHARMA. H YC1 defensive interval ratio. BIOCYTOGEN PHARMA. H YC1 (I54) has a Defensive Interval Ratio of 118 days as of December 2025. Defensive assets of €300.14 Million (cash €-, short-term investments €-, receivables €300.14 Million) cover 118 days of daily cash needs of €2.55 Million/day. See BIOCYTOGEN PHARMA. H YC1 current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of BIOCYTOGEN PHARMA. H YC1 (2021–2025)
Defensive interval ratio of BIOCYTOGEN PHARMA. H YC1 from 2021 to 2025. This chart shows how BIOCYTOGEN PHARMA. H YC1's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 118 days, meaning defensive assets of €300.14 Million can fund 118 days of operations without new revenue. Check BIOCYTOGEN PHARMA. H YC1 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
BIOCYTOGEN PHARMA. H YC1 Defensive Interval Ratio by Year (2021–2025)
BIOCYTOGEN PHARMA. H YC1 defensive interval ratio by year from 2021 to 2025. The table below presents the year-by-year Defensive Interval Ratio for BIOCYTOGEN PHARMA. H YC1 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see BIOCYTOGEN PHARMA. H YC1 (I54) total assets.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 118 days | €300.14 Million | €2.55 Million/day | €- | €- | ▼ -39 days |
| 2024 | 157 days | €229.45 Million | €1.47 Million/day | €- | €- | ▲ +61 days |
| 2023 | 95 days | €150.69 Million | €1.58 Million/day | €- | €8.49 Million | ▲ +25 days |
| 2022 | 70 days | €115.88 Million | €1.66 Million/day | €- | €8.20 Million | ▼ -96 days |
| 2021 | 166 days | €203.09 Million | €1.22 Million/day | €- | €100.00 Million | — |